Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02875561 · ClinicalTrials.gov registry record · NA
Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02875561 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 47 participants.
The verdict
NCT02875561, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the incidence of vulva dysplasia recurrence within 12 months of treatment with Carbon Dioxide (CO2) laser ablation or ultrasonic aspiration.
Interventions
- DEVICE Sonopet Ultrasonic Aspirator
- DEVICE CO2 Laser Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-03-26 |
| Est. Completion | 2023-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02875561
The ClinicalTrials.gov registry entry for NCT02875561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sonopet Ultrasonic Aspirator is the first listed.
NCT02875561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02875561 about?
NCT02875561 is a clinical study titled "Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia". The primary objective of this study is to evaluate the incidence of vulva dysplasia recurrence within 12 months of treatment with Carbon Dioxide (CO2) laser ablation or ultrasonic aspiration.
What is the current status of trial NCT02875561?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2017-03-26. Estimated completion is 2023-04-20.
What interventions are being tested in trial NCT02875561?
The interventions under investigation include: Sonopet Ultrasonic Aspirator (DEVICE), CO2 Laser Ablation (DEVICE).
Who is sponsoring clinical trial NCT02875561?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.